home / stock / rylpf / rylpf news


RYLPF News and Press, Koninklijke Philips NV From 01/31/24

Stock Information

Company Name: Koninklijke Philips NV
Stock Symbol: RYLPF
Market: OTC
Website: philips.com

Menu

RYLPF RYLPF Quote RYLPF Short RYLPF News RYLPF Articles RYLPF Message Board
Get RYLPF Alerts

News, Short Squeeze, Breakout and More Instantly...

RYLPF - New Philips Mini TEE ultrasound transducer helps improve cardiac care for more patients

January 31, 2023 Latest innovation has the potential to reduce anesthesia during minimally invasive procedures [1] As a pioneer and leading innovator in cardiac ultrasound, Philips has developed the smaller X11- 4t Mini 3D TEE transducer to serve more patients with this valuable i...

RYLPF - ResMed positive as Philips halts sales of sleep therapy devices

2024-01-29 12:49:51 ET More on ResMed ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript ResMed Inc. 2024 Q2 - Results - Earnings Call Presentation Why ResMed Is One Of My Top Picks In 2024 ResMed jumps 9% as quarterly results shine ResMed Q2 2024 Ear...

RYLPF - Koninklijke Philips N.V. (PHG) Q4 2023 Earnings Call Transcript

2024-01-29 07:31:02 ET Koninklijke Philips N.V. (PHG) Q4 2023 Earnings Conference Call January 29, 2024 04:00 AM ET Company Participants Leandro Mazzoni - Head-Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer ...

RYLPF - Philips delivers strong full-year results; agrees with FDA on terms of consent decree focused on Philips Respironics in the US

January 29, 2024 Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 plan Agrees with FDA on terms of consent decree focused on Philips Respironics in the US, providing clarity and a roadmap to demonstrate...

RYLPF - Koninklijke Philips: Still On The Cautious Line

2024-01-24 11:49:00 ET Summary We see no positive catalyst into 2024. On the contrary, the Respironics settlement might weigh on the company's share price. After the JPM healthcare conference, the CEO refrained from commenting on FDA potential outcomes. Given a higher outlook,...

RYLPF - ResMed product recall classified as most serious by FDA

2024-01-18 15:04:14 ET More on ResMed ResMed: Putting GLP-1 Myths To Sleep ResMed: A Buy For Investors Seeking Long-Term Rewards A First Look At ResMed ResMed masks to remain on market despite recall: report ResMed alerts customers to potential magnet...

RYLPF - Philips completes cancellation of 15.1 million shares

December 19, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 15,134,054 of its shares. The cancelled shares were acquired as part of the EUR 1.5 billion share repurchase program for capital red...

RYLPF - Siemens Healthineers: A High Quality Option In The Healthcare Industry

2023-12-06 15:54:55 ET Summary Siemens Healthineers demonstrates operational superiority and holds a competitive edge in the healthcare industry. With top-tier financial metrics and industry-leading margins, the company outperforms its peers. The company holds the number one or tw...

RYLPF - GE Healthcare: Unveiling Red Flags In Its Growth Story

2023-12-02 04:08:02 ET Summary GE Healthcare Technologies Inc. faces significant competition and market share losses, leading to an undeserved premium and overly ambitious financial targets. GE Healthcare's Imaging segment struggles to maintain market share, while the Ultrasound m...

RYLPF - Research from Philips and Vanderbilt shows how decarbonizing healthcare also helps to reduce cost

November 29, 2023 Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to top-ranked adult and pediatric hospitals in the Southeastern U.S., tod...

Previous 10 Next 10